Extended-spectrum beta-lactamases: the end of cephalosporins?
Colodner
Raul
R
Raz
Raul
R
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects*; D018550:Cephalosporin Resistance / Q000502:physiology*; D002511:Cephalosporins / Q000494:pharmacology; D006801:Humans; D007557:Israel; D012307:Risk Factors; D001618:beta-Lactamases / Q000096:biosynthesis / Q000187:drug effects
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D001618:beta-Lactamases